Get started
Author

Héctor Picón

Observed names: Hector Picon, Picon, Hector
OpenAlex ID: A5040536409
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation
2021 · Roxana Mehran, Davide Cao, et al. · JACC: Cardiovascular Interventions · 109
PDF
Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI
2021 · Marco Valgimigli, Davide Cao, et al. · Journal of the American College of Cardiology · 86
Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention
2017 · Muthiah Vaduganathan, Robert A. Harrington, et al. · Journal of the American College of Cardiology · 58
PDF
Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stent
2020 · Marco Valgimigli, Davide Cao, et al. · American Heart Journal · 35
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI
2023 · Marco Valgimigli, Alessandro Spirito, et al. · JACC: Cardiovascular Interventions · 10
1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCI
2025 · Vijay Kunadian, Mauro Gitto, et al. · JACC: Cardiovascular Interventions · 7
PDF
One-Month Versus Three-Month Dual-Antiplatelet Therapy in High Bleeding Risk Patients With Chronic Kidney Disease
2024 · Nader Mankerious, Ralph Toelg, et al. · The American Journal of Cardiology · 6
One- versus three-month DAPT after everolimus-eluting stent implantation in diabetic patients at high bleeding risk: results from the XIENCE Short DAPT programme
2025 · Angelo Oliva, Dominick J. Angiolillo, et al. · EuroIntervention · 4
One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes
2024 · Davide Cao, Pascal Vranckx, et al. · EuroIntervention · 4
PDF
1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global Program
2024 · Gennaro Sardella, Alessandro Spirito, et al. · The American Journal of Cardiology · 4
PDF
Abbreviated DAPT Regimens Across the Entire Spectrum of Bleeding Risk According to the PRECISE-HBR Score
2026 · Davide Cao, Angelo Oliva, et al. · JACC: Cardiovascular Interventions · 2
Baseline anaemia and short dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention
2026 · Francesca Maria Di Muro, Samantha Sartori, et al. · European Journal of Preventive Cardiology · 1
Baseline Anemia and Short Dual Antiplatelet Therapy in High Bleeding Risk Patients Undergoing Percutaneous Coronary Intervention.
2026 · Di Muro, Francesca Maria, Sartori, Samantha, et al. · Open Access CRIS of the University of Bern
TCT-996 One-versus three-month DAPT in High Bleeding Risk Patients With or Without Baseline Anemia Undergoing PCI
2025 · Francesca Maria Di Muro, Marco Valgimigli, et al. · Journal of the American College of Cardiology
TCT-239 Efficacy and Safety of Short-Infusion Tirofiban in Patients Undergoing Percutaneous Coronary Intervention: The SAVI-PCI Trial
2021 · Jorge Saucedo, Matthew Price, et al. · Journal of the American College of Cardiology
Works count: 18
Citation count: 326
H-index: 6
I10-index: 5
Year
Topic
Type